Vijay et al., 2014 - Google Patents
Ion exchange resins and their applicationsVijay et al., 2014
View PDF- Document ID
- 14221738706209543950
- Author
- Vijay S
- Dr C
- Publication year
- Publication venue
- Journal of Drug Delivery & Therapeutics
External Links
Snippet
Ion exchange resins are cross-linked water insoluble polymer-carrying, ionisable functional groups. IER have received considerable attention from pharmaceutical scientists because of their versatile properties as drug delivery vehicles. Research over the last few years has …
- 239000003456 ion exchange resin 0 title abstract description 70
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
- A61K47/48176—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol
- A61K47/48184—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol the macromolecular compound obtained by reactions only involving carbon-to-carbon unsaturated bonds being an ion exchange resin, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guo et al. | Ion-exchange resins as drug delivery carriers | |
Srikanth et al. | Ion-exchange resins as controlled drug delivery carriers | |
Vijay et al. | Ion exchange resins and their applications | |
Anand et al. | Ion-exchange resins: carrying drug delivery forward | |
Singh et al. | Ion exchange resins: Drug delivery and therapeutic applications | |
US4221778A (en) | Prolonged release pharmaceutical preparations | |
Borodkin | Ion-exchange resin delivery systems | |
US8377480B2 (en) | Granular sustained release preparation and production thereof | |
FI87525B (en) | FOERFARANDE FOER FRAMSTAELLNING AV EN FARMACEUTISK HARTSKOMPOSITION MED KONTROLLERAD FOERDROEJD FRIGIVNING AV DEXTROMETORFANHYDROBROMID | |
US20080081072A1 (en) | Resin-complex granulation for water-soluble drugs and associated methods | |
Elder | Pharmaceutical applications of ion-exchange resins | |
Shukla et al. | Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets | |
US20060115529A1 (en) | Fast-melting tablets having taste-masking and sustained release properties | |
IE62765B1 (en) | Substained release drug-resin complexes | |
HU218661B (en) | A method for the preparation of pharmaceutical forms comprising a complex of pharmaceutically active ionic drug and ion exchange resin | |
IE45998B1 (en) | Prolonged release pharmaceutical preparations | |
AU666887B2 (en) | New drug formulations with ion-exchangers | |
Pande et al. | Ion exchange resins pharmaceutical applications and recent advancement | |
Gao et al. | Loading and release of amine drugs by ion-exchange fibers: role of amine type | |
EP3727340B1 (en) | Pharmaceutical composition containing crosslinked ion exchange resin | |
Kaushik et al. | Ion exchange resin complexation technique for pharmaceutical taste masking: An overview | |
Saha et al. | Intriguing clinical and pharmaceutical applications of IERs: A mini review | |
INAL et al. | Ion exchange resins and applications in pharmaceutical technology | |
Gupta et al. | Ion exchange resins transforming drug delivery systems | |
Bajpai et al. | Ion exchange resins in drug delivery |